C07C 215/02
Compounds containing amino and hydroxy groups bound to the same carbon skeleton
Official title: having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
C07C215/02 (Compounds containing amino and hydroxy groups bound to the same carbon skeleton) appears on 1,090 US grants and 1,041 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,090
- Published applications
- 1,041
- Assignees
- 686
- Inventors
- 3,037
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 9 | 0 |
| 1977 | 4 | 0 |
| 1978 | 5 | 0 |
| 1979 | 4 | 0 |
| 1980 | 3 | 0 |
| 1981 | 4 | 0 |
| 1982 | 3 | 0 |
| 1983 | 5 | 0 |
| 1984 | 3 | 0 |
| 1985 | 2 | 0 |
| 1986 | 4 | 0 |
| 1987 | 4 | 0 |
| 1988 | 10 | 0 |
| 1989 | 14 | 0 |
| 1990 | 11 | 0 |
| 1991 | 18 | 0 |
| 1992 | 26 | 0 |
| 1993 | 24 | 0 |
| 1994 | 15 | 0 |
| 1995 | 21 | 0 |
| 1996 | 46 | 0 |
| 1997 | 51 | 0 |
| 1998 | 42 | 0 |
| 1999 | 21 | 0 |
| 2000 | 20 | 0 |
| 2001 | 19 | 6 |
| 2002 | 26 | 28 |
| 2003 | 23 | 47 |
| 2004 | 32 | 29 |
| 2005 | 15 | 34 |
| 2006 | 19 | 29 |
| 2007 | 17 | 29 |
| 2008 | 22 | 34 |
| 2009 | 23 | 41 |
| 2010 | 20 | 38 |
| 2011 | 17 | 42 |
| 2012 | 24 | 51 |
| 2013 | 36 | 47 |
| 2014 | 47 | 66 |
| 2015 | 42 | 58 |
| 2016 | 43 | 43 |
| 2017 | 30 | 48 |
| 2018 | 27 | 54 |
| 2019 | 35 | 48 |
| 2020 | 48 | 55 |
| 2021 | 38 | 53 |
| 2022 | 34 | 37 |
| 2023 | 31 | 41 |
| 2024 | 16 | 34 |
| 2025 | 25 | 29 |
| 2026 | 12 | 20 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Process for the preparation of (9S)-2-bromo-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4]triazolo[1,5-A]azepine6 Oct 2026US 12,753,175 B2Hoffmann-La Roche Inc.
- Cannabinoid sulfate esters, their salts and uses thereof16 Jun 2026US 12,655,094 B2London Pharmaceuticals and Research Corporation
- Ionizable lipid compounds and lipid nanoparticle compositions16 Jun 2026US 12,655,114 B2SunVax mRNA Therapeutics Inc.
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid19 May 2026US 12,629,421 B2Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Stereoselective process for preparing substituted polycyclic pyridone28 Apr 2026US 12,612,415 B2Shionogi & Co., Ltd.
- Method of synthesis8 Oct 2026US 2026/0308107 A1Mitocholine Ltd.
- Crystalline forms or salts of a deuterated compound13 Aug 2026US 2026/0234135 A1Alebund Pharmaceuticals (Hong Kong) Limited
- Artificially synthesized sphingosine derivative lipoid monomer and use of same for delivering nucleic acid6 Aug 2026US 2026/0224704 A1Beijing Baishihekang Pharmaceutical Technology (Bsjpharma) Co., Ltd
- Pharmaceutically acceptable salt and crystal form of triazole compound, and preparation method therefor6 Aug 2026US 2026/0226025 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
- Salt and crystal form of cycloalkene compound, and preparation method therefor and use thereof6 Aug 2026US 2026/0226046 A1Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Most cited
By later US patents
- Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods234US 5,414,077 AGilead Sciences, Inc. · 1995
- Aminoalcohol lipidoids and uses thereof207US 8,450,298 B2Massachusetts Institute of Technology · 2013
- Electrochemical assay method with novel p-phenylenediamine compound196US 5,609,749 AMochida Pharmaceutical Co., Ltd. · 1997
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Modulators of ATP-binding cassette transporters157US 7,495,103 B2Vertex Pharmaceuticals Incorporated · 2009